Risk factors and progression of the left ventricular myocardial hypertrophy

Bibliography:
1. Lorell BH. Transition from hypertrophy to failure. Circulation 1997;96:3824-7
2. Molkentin JD, Olson EN. GATA4: a novel transcriptional regulator of cardiac hypertrophy? Circulation 1997; 96: 3833-5
3. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322 (22): 1561-6
4. Koren M, Richard B, Devereux M, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52
5. Shherbakova AG. Remodeling of left ventricle at stage of chronic kidney disease. Vestnik sovremennoj klinicheskoj medici-ny 2010; 3 (1): 209-210
6. Levy Bl, et al. Coronary microvasculature alteration in hypertensive rats: effects of treatment with diuretic and an ACE inhibitor. Am J Hypertens 2001; 14: 7-13
7. Shherbakova ТА, Aleksandrova NL. Risk factors and left ventricular hypertrophies of patients with arterial hypertension in Saratov region. Bjulleten' medicinskih Internet konferencij 2013; 3 (2):133
8. Diagnosis and treatment of arterial hypertension: Recommendations RMSAH and RSSC. Kardiovaskuljarnaja terapija i profilaktika 2008; 7 (6): 1-32
9. The Russian medical society of hypertension. Diagnosis and treatment of hypertension: Rossijskie rekomendacii (4-j peresmotr). Sistemnye gipertenzii 2010; 3: 5-33
10. Schillaci G, Verdecchia Р, Porcellatti С, et al. Continuous relation between left ventricular mass and cardiovascular risk is essential hypertension. Hypertension 2000; 35: 580-6
11. Gottdienner JS, Reda DJ, Materson BJ, et al. Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. J Am Coll Cardiol 1994; 24: 1492-8
12. Order №796 of Health Ministry "On approval of the list of medical contra-indications to work directly related to trains and shunting", http://base.consultant.ru
13. Klochkova ЕА. Labour Protection on railway transport: Textbook for technical schools and colleges. M., 2004; 412 p.
14. Cardiovascular prevention: Recommendations of RSSC. Kardiovaskuljarnaja terapija i profilaktika 2011; 10 (6): 1-64
15. Atkov OYu, ed. Ultrasound examination of heart and blood vessels. Ed. by M.: EKSMO, 2009; 400 p.
16. Poirier Р, Giles Т, Bray G, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effects of weight loss: An update of the 1997 american heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006; 113: 898-918
17. Neves MF, Schiffrin EL, Aldosterone: a risk factor for vascular diseases. Cur Hypertens Rep 2003; 5: 59-65
18. Sato A, Saruta T, Aldosterone escape during angioten-sin-converting enzyme inhibitor therapy in essential hypertensive patients with left ventricular hypertrophy. J Intern Med Res 2001; 29: 13-21
19. Hameedi A, Shadow HL., The promise of selective aldosterone receptor antagonists for the treatment of Hypertension and Chronic Heart Failure. Cur Hypertens Rep 2000; 2: 378-83
20. Mychka VB, Gornostaev VV, Shikina NJu, Chazo-va IE. Hypertension and obesity. Cons med 2001; 2: 17-22
21. Kamm AJ, Luscher TF, Serruys PW. Diseases of heart and vessels. M.: GEOTAR-Media, 2011; 1211 p.
22. Shalimov РМ. Clinicopathological analysis of three cases of sudden cardiac death of young people. Kliniches-kaja medicina 2006; 10: 71-74
23. Guide postprandial hyperglycemia. International Diabetes Federation, 2007; 29 p.
24. Ripp TM, Mordovin VF. Peripheral progression markers of target-organ lesions of patients with hypertension. Sibir-skij medicinskij zhurnal 2008; 2: 126-127
25. Paraskevas Kl, Mikhailidis DP, Liapis CD. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors. Angiology 2007; 58: 329-335
26. Park HW, Kim WH, Kim KH, et at. Carotid plaque is associated with increased cardiac mortality in patients with coronary artery disease. Int J Cardiol 2013; 166: 658-663
27. Barbarash OL, Zykov MV, Kashtalap VV, Barbarash LS. Prevalence and clinical significance of multifocal atherosclerosis in patients with ischemic heart disease. Kardiologiia 2011; 51: 66-71
28. Pipitone S, Corrado E, Muratori I, et al. Extracoronary atherosclerosis in patients with chronic ischemic heart disease: relationship with risk factors and the severity of coronary artery disease. Int Angiol 2007; 26: 346-352
29. Keo HH, Baumgartner I, HirschAT, etal. Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease. Vase Med 2011; 16:323-330
30. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima — media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012; 220: 128-133
31. Sillesen H, Muntendam P, Adourian A, et al. Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque Biolmage study. JACC Cardiovasc Imaging 2012; 5: 681-689.